Experimental evaluation of toxicity of MDM2 inhibitors obtained in mouse models suggests that tumor-suppressing doses of nutlin3a, RITA, MI-219, and stapled peptide ATSP-7041 do not cause weight loss and are well tolerated (Chang et al., 2013). Here, MDM2 is linked to neoplasm.